Ozlem Tureci, BioNTech Founder talks about developing a vaccine for cancer during an interview. BioNTech, a German pharmaceutical company became popular after it developed the coronavirus vaccine.
The BioNTech founder who delivered the first widely used COVID-19 vaccine assured people of the efficacy and safety of the shots and the technology responsible for them. She further maintained that this technology will soon be used in combating cancer.
Ozlem Tureci, who co-founded BioNTech with her husband, maintained that she had been making efforts to look for a way to harness the immune system of the body to fight tumors before Coronavirus began. The couple applied the technology they had been researching for twenty years to the new threat.
The U.K authorized the emergency use of the mRNA vaccine BioNTech developed alongside Pfizer with 11 months. A week after, the United States also authorized the vaccine use. The vaccine has been administered to tens of millions of people across the world.
It pays off to make bold decisions and to trust that if you have an extraordinary team, you will be able to solve any problem and obstacle which comes your way in real time.Tureci
According to Tureci, she and her husband, the chief executive of BioNTech, learned the importance of global collaboration and cooperation.
As BioNTech gained popularity amid the pandemic, so has its value. This has helped the company acquire funds it can use to accomplish its original goal of creating a new tool to fight cancer.
The vaccines BioNTech-Pfizer and U.S. rival Moderna developed make use of messenger RNA, or mRNA, to make proteins that trigger it to fight a specific virus. Scientists can apply this same procedure to get the immune system to take on tumors.